Episode 102: U.S. Food and Drug Administration Recognizes Oncology Nursing Month
Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE), joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss oncology nurses’ contributions to cancer care, OCE’s initiatives, and the COVID-19 coronavirus pandemic’s implications for oncology drug approvals.
Episode Notes
Check out these resources from today’s episode:
- FDA new drug approval announcements on ONS Voice
- Richard Pazdur’s biography
- Oncology Center of Excellence
- FDA Guidance on Conduct of Clinical Trials During COVID-19
- FDA Community Outreach and Education Programs
- Project Facilitate
- Project Orbis
- Register for the Mosaic of Oncology Nursing webinar on May 19 from 2–3 pm EST.
- COVID-19 articles on ONS Voice
- ONS Information Regarding the Coronavirus (COVID-19)
- ONS Interim PPE Guidelines During the COVID-19 Pandemic
To discuss the information in this episode with other oncology nurses, visit the ONS Communities.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Listen on:
Listen on iTunes, Listen on Google Podcasts, Listen on Stitcher, Listen on Spotify, Listen on Amazon Music